Titan Biotech

  • Market Cap: Micro Cap
  • Industry: Specialty Chemicals
  • ISIN: INE150C01029
  • NSEID:
  • BSEID: 524717
INR
415.85
15.7 (3.92%)
BSENSE

Mar 25

BSE+NSE Vol: 90.22 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Titan Biotech
Yasho Industries
Bhansali Engg.
Indokem
Rossari Biotech
Platinum Industr
Vidhi Specialty
Excel Industries
S H Kelkar & Co.
Camlin Fine
Paushak

Why is Titan Biotech Ltd ?

1
Company has a low Debt to Equity ratio (avg) at 0.04 times
2
With a growth in Net Profit of 107.11%, the company declared Very Positive results in Dec 25
  • The company has declared positive results for the last 2 consecutive quarters
  • PBT LESS OI(Q) Highest at Rs 9.30 cr.
  • NET SALES(Q) Highest at Rs 56.51 cr
  • PBDIT(Q) Highest at Rs 10.84 cr.
3
Market Beating performance in long term as well as near term
  • Along with generating 342.39% returns in the last 1 year, the stock has outperformed BSE500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to Titan Biotech should be less than 10%
  2. Overall Portfolio exposure to Specialty Chemicals should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Specialty Chemicals)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Titan Biotech for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Titan Biotech
342.39%
5.39
63.50%
Sensex
-3.52%
-0.27
12.93%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
8.72%
EBIT Growth (5y)
-6.32%
EBIT to Interest (avg)
26.27
Debt to EBITDA (avg)
0.26
Net Debt to Equity (avg)
0.03
Sales to Capital Employed (avg)
1.22
Tax Ratio
25.09%
Dividend Payout Ratio
6.65%
Pledged Shares
0
Institutional Holding
0.03%
ROCE (avg)
25.43%
ROE (avg)
21.23%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
61
Industry P/E
37
Price to Book Value
9.94
EV to EBIT
57.19
EV to EBITDA
49.56
EV to Capital Employed
9.66
EV to Sales
8.61
PEG Ratio
2.90
Dividend Yield
0.10%
ROCE (Latest)
13.46%
ROE (Latest)
13.86%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

28What is working for the Company
PBT LESS OI(Q)

Highest at Rs 9.30 cr.

NET SALES(Q)

Highest at Rs 56.51 cr

PBDIT(Q)

Highest at Rs 10.84 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 19.18%

PAT(Q)

Highest at Rs 8.53 cr.

EPS(Q)

Highest at Rs 10.33

-3What is not working for the Company
ROCE(HY)

Lowest at 16.04%

DEBTORS TURNOVER RATIO(HY)

Lowest at 5.88 times

Loading Valuation Snapshot...

Here's what is working for Titan Biotech

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 9.30 cr has Grown at 164.96%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 8.53 cr has Grown at 94.3%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Net Sales - Quarterly
At Rs 56.51 cr has Grown at 47.62%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 9.30 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Net Sales - Quarterly
Highest at Rs 56.51 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 10.84 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 19.18%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Profit After Tax (PAT) - Quarterly
Highest at Rs 8.53 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 10.33
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Here's what is not working for Titan Biotech

Debtors Turnover Ratio- Half Yearly
Lowest at 5.88 times
in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio